The Relevance of Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease: A Review For Clinicians.


Journal

Clinics in chest medicine
ISSN: 1557-8216
Titre abrégé: Clin Chest Med
Pays: United States
ID NLM: 7907612

Informations de publication

Date de publication:
06 2019
Historique:
entrez: 13 5 2019
pubmed: 13 5 2019
medline: 20 2 2020
Statut: ppublish

Résumé

"Chronic obstructive pulmonary disease (COPD) is often accompanied by extrapulmonary manifestations such as limb muscle dysfunction. This term encompasses several features, including atrophy, weakness, and reduced oxidative capacity. Clinicians should become accustomed with this manifestation of COPD because of its relevance for important outcomes such as exercise tolerance and survival. Measuring muscle strength and mass can be performed with simple and valid tools that could be implemented in clinical practice. One identified, limb muscle dysfunction is amenable to therapy such as exercise training that has been repeatedly shown to improve muscle mass, strength, and oxidative capacity in COPD."

Identifiants

pubmed: 31078215
pii: S0272-5231(19)30013-9
doi: 10.1016/j.ccm.2019.02.013
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

367-383

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Kim-Ly Bui (KL)

Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, 2725 chemin SteFoy, Université Laval, Québec G1V4G5, Canada.

André Nyberg (A)

Department of Community Medicine and Rehabilitation, Section of Physiotherapy. Umeå University, Umeå, Sweden.

Roberto Rabinovich (R)

ELEGI and COLT Laboratories, Queen's Medical Research Institute, The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK; Department of Respiratory Medicine, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH 16 4SA, UK.

Didier Saey (D)

Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, 2725 chemin SteFoy, Université Laval, Québec G1V4G5, Canada.

François Maltais (F)

Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Québec, 2725 chemin SteFoy, Université Laval, Québec G1V4G5, Canada. Electronic address: Francois.maltais@med.ulaval.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH